Angiotensin Inhibitors And Receptor Blockers Linked To Lower Risk Of Nonmelanoma Skin Cancer

The use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a reduced risk of basal cell or squamous cell skin cancers in US veterans, researchers report in the Aug. 26 online issue of the Journal of the National Cancer Institute.

Read the whole article on Science Daily

More from Science Daily